1. Home
  2. WS vs GHRS Comparison

WS vs GHRS Comparison

Compare WS & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$37.76

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$29.08

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
GHRS
Founded
1955
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
WS
GHRS
Price
$37.76
$29.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$42.50
$41.38
AVG Volume (30 Days)
200.4K
304.9K
Earning Date
03-25-2026
05-01-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$3,443,800,000.00
N/A
Revenue This Year
$16.77
N/A
Revenue Next Year
$2.69
N/A
P/E Ratio
$224.59
N/A
Revenue Growth
11.33
N/A
52 Week Low
$27.22
$11.83
52 Week High
$49.17
$31.44

Technical Indicators

Market Signals
Indicator
WS
GHRS
Relative Strength Index (RSI) 58.21 62.73
Support Level $38.01 $12.83
Resistance Level $39.02 $31.00
Average True Range (ATR) 1.79 1.39
MACD 0.36 0.04
Stochastic Oscillator 79.72 72.08

Price Performance

Historical Comparison
WS
GHRS

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: